Cargando…
Reversible splenial lesion syndrome with a hyperosmolar hyperglycemic state and neuroleptic malignant syndrome caused by olanzapine
A 27‐year‐old woman with panic disorder taking 20 mg olanzapine daily for 4 months was admitted to Mito Kyodo General Hospital, Mito, Ibaraki, Japan, because of disturbed consciousness with fever, hyperglycemia, hyperosmolarity and elevated creatine phosphokinase. She was diagnosed with a hyperosmol...
Autores principales: | Kaino, Kenta, Kumagai, Ryo, Furukawa, Shoko, Isono, Momoko, Muramatsu, Aiko, Fujii, Masanao, Muta, Yumiko, Asada, Tomoyuki, Fujihara, Kazuya, Yagyu, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415487/ https://www.ncbi.nlm.nih.gov/pubmed/27863115 http://dx.doi.org/10.1111/jdi.12597 |
Ejemplares similares
-
Reversible splenial lesion syndrome in neuroleptic malignant syndrome
por: Al-Edrus, SA, et al.
Publicado: (2009) -
Olanzapine induced neuroleptic malignant syndrome
por: Patra, Bichitra Nanda, et al.
Publicado: (2013) -
Olanzapine-Induced Neuroleptic Malignant Syndrome
por: Hosseini, Seyedhamze, et al.
Publicado: (2017) -
Olanzapine-induced Neuroleptic Malignant Syndrome
por: Saha, Pradeep Kumar, et al.
Publicado: (2017) -
Homonymous quadrantanopia associated with hyperosmolar hyperglycemic syndrome
por: Mizuguchi, Chika, et al.
Publicado: (2020)